| Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study) WP Brouwer, Q Xie, MJ Sonneveld, N Zhang, Q Zhang, F Tabak, ... Hepatology 61 (5), 1512-1522, 2015 | 201 | 2015 |
| Toronto HCC risk index: a validated scoring system to predict 10-year risk of HCC in patients with cirrhosis SA Sharma, M Kowgier, BE Hansen, WP Brouwer, R Maan, D Wong, ... Journal of hepatology 68 (1), 92-99, 2018 | 157 | 2018 |
| Nonalcoholic steatohepatitis is associated with liver‐related outcomes and all‐cause mortality in chronic hepatitis B HSJ Choi, WP Brouwer, WMR Zanjir, RA de Man, JJ Feld, BE Hansen, ... Hepatology 71 (2), 539-548, 2020 | 150 | 2020 |
| Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective … WP Brouwer, S Duran, M Kuijper, C Ince Critical Care 23 (1), 1-9, 2019 | 148 | 2019 |
| The membrane‐bound O‐acyltransferase domain‐containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B K Thabet, HLY Chan, S Petta, A Mangia, T Berg, A Boonstra, WP Brouwer, ... Hepatology 65 (6), 1840-1850, 2017 | 83 | 2017 |
| Repeated measurements of hepatitis B surface antigen identify carriers of inactive HBV during long-term follow-up WP Brouwer, HLY Chan, MR Brunetto, M Martinot-Peignoux, P Arends, ... Clinical Gastroenterology and Hepatology 14 (10), 1481-1489. e5, 2016 | 65 | 2016 |
| CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses M Spaan, K Kreefft, GN de Graav, WP Brouwer, RJ de Knegt, ... Journal of hepatology 62 (2), 303-310, 2015 | 63 | 2015 |
| Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study MJ Sonneveld, WP Brouwer, HLY Chan, T Piratvisuth, JD Jia, S Zeuzem, ... The Lancet Gastroenterology & Hepatology 4 (7), 538-544, 2019 | 58 | 2019 |
| Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B LA van Kleef, HSJ Choi, WP Brouwer, BE Hansen, K Patel, RA de Man, ... Jhep Reports 3 (5), 100350, 2021 | 55 | 2021 |
| The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long‐term clinical outcome in chronic hepatitis B patients WP Brouwer, AJ van der Meer, A Boonstra, SD Pas, RJ de Knegt, ... Liver International 35 (2), 438-447, 2015 | 37 | 2015 |
| Prediction of long‐term clinical outcome in a diverse chronic hepatitis B population: role of the PAGE‐B score WP Brouwer, AJP Van Der Meer, A Boonstra, EPC Plompen, SD Pas, ... Journal of viral hepatitis 24 (11), 1023-1031, 2017 | 34 | 2017 |
| Hepatitis B core-related antigen levels are associated with response to entecavir and peginterferon add-on therapy in hepatitis B e antigen–positive chronic hepatitis B patients MJH van Campenhout, WP Brouwer, GW van Oord, Q Xie, Q Zhang, ... Clinical Microbiology and Infection 22 (6), 571. e5-571. e9, 2016 | 31 | 2016 |
| Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B KS Liem, MJH van Campenhout, Q Xie, WP Brouwer, H Chi, X Qi, L Chen, ... Alimentary Pharmacology & Therapeutics 49 (4), 448-456, 2019 | 30 | 2019 |
| Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis MJ Sonneveld, WP Brouwer, BE Hansen, HLY Chan, T Piratvisuth, JD Jia, ... Alimentary pharmacology & therapeutics 52 (8), 1399-1406, 2020 | 29 | 2020 |
| Real life adherence of chronic hepatitis B patients to entecavir treatment LG van Vlerken, P Arends, FI Lieveld, JE Arends, WP Brouwer, ... Digestive and liver disease 47 (7), 577-583, 2015 | 27 | 2015 |
| Polymorphisms of HLA‐DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B WP Brouwer, MJ Sonneveld, F Tabak, K Simon, Y Cakaloglu, US Akarca, ... Alimentary pharmacology & therapeutics 40 (7), 811-818, 2014 | 26 | 2014 |
| A STAT 4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B R El Sharkawy, K Thabet, P Lampertico, S Petta, A Mangia, T Berg, ... Alimentary Pharmacology & Therapeutics 48 (5), 564-573, 2018 | 24 | 2018 |
| Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality LA Van Kleef, RJ De Knegt, WP Brouwer Hepatology 77 (3), 942-948, 2023 | 21 | 2023 |
| Machine-learning based patient classification using Hepatitis B virus full-length genome quasispecies from Asian and European cohorts AJ Mueller-Breckenridge, F Garcia-Alcalde, S Wildum, SL Smits, ... Scientific Reports 9 (1), 18892, 2019 | 21 | 2019 |
| Unique intrahepatic transcriptomics profiles discriminate the clinical phases of a chronic HBV infection J Hou, WP Brouwer, K Kreefft, L Gama, SL Price, HLA Janssen, PJ French, ... PloS one 12 (6), e0179920, 2017 | 21 | 2017 |
Harry L.A. JanssenProfessor of Medicine, University of Toronto在 uhn.ca 的电子邮件经过验证
